Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Neoplasms | 82 | 2023 | 4312 | 5.790 |
Why?
|
Carcinoma, Hepatocellular | 47 | 2023 | 2295 | 4.760 |
Why?
|
Hepatectomy | 27 | 2021 | 562 | 3.790 |
Why?
|
Herpesvirus 1, Human | 18 | 2023 | 753 | 3.200 |
Why?
|
Kidney Transplantation | 94 | 2017 | 4216 | 3.050 |
Why?
|
Liver Cirrhosis | 30 | 2024 | 1925 | 2.500 |
Why?
|
Cholangiocarcinoma | 15 | 2021 | 546 | 2.250 |
Why?
|
Bile Duct Neoplasms | 14 | 2021 | 601 | 2.210 |
Why?
|
ABO Blood-Group System | 22 | 2015 | 369 | 2.000 |
Why?
|
Oncolytic Virotherapy | 10 | 2015 | 515 | 1.980 |
Why?
|
Blood Group Incompatibility | 17 | 2015 | 135 | 1.960 |
Why?
|
Melanoma | 46 | 2023 | 5692 | 1.900 |
Why?
|
Graft Survival | 47 | 2016 | 3789 | 1.690 |
Why?
|
Colonic Neoplasms | 21 | 2014 | 2519 | 1.540 |
Why?
|
Graft Rejection | 49 | 2017 | 4418 | 1.420 |
Why?
|
Adenoma, Liver Cell | 2 | 2020 | 32 | 1.420 |
Why?
|
Hepatic Stellate Cells | 5 | 2024 | 117 | 1.380 |
Why?
|
Skin Neoplasms | 33 | 2023 | 5796 | 1.360 |
Why?
|
Liver | 29 | 2024 | 7514 | 1.280 |
Why?
|
Immunosuppressive Agents | 42 | 2015 | 4168 | 1.230 |
Why?
|
Sentinel Lymph Node Biopsy | 13 | 2020 | 726 | 1.080 |
Why?
|
Oncolytic Viruses | 5 | 2015 | 343 | 1.060 |
Why?
|
Virus Replication | 17 | 2023 | 2431 | 1.030 |
Why?
|
Tacrolimus | 14 | 2008 | 730 | 1.020 |
Why?
|
Liver Neoplasms, Experimental | 6 | 2020 | 189 | 0.930 |
Why?
|
Simplexvirus | 7 | 2012 | 803 | 0.890 |
Why?
|
Fluorouracil | 11 | 2024 | 1620 | 0.820 |
Why?
|
Epidermal Growth Factor | 6 | 2016 | 695 | 0.810 |
Why?
|
Carbon Tetrachloride | 6 | 2024 | 72 | 0.810 |
Why?
|
Molecular Imaging | 5 | 2020 | 817 | 0.790 |
Why?
|
Peroxidases | 1 | 2022 | 135 | 0.780 |
Why?
|
Quinazolines | 5 | 2017 | 1362 | 0.730 |
Why?
|
Colorectal Neoplasms | 20 | 2023 | 6853 | 0.730 |
Why?
|
Stomach Neoplasms | 7 | 2017 | 1422 | 0.730 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2020 | 29 | 0.710 |
Why?
|
Cyclosporine | 13 | 2000 | 778 | 0.710 |
Why?
|
Bile Ducts, Intrahepatic | 7 | 2021 | 298 | 0.710 |
Why?
|
Endostatins | 5 | 2012 | 168 | 0.700 |
Why?
|
Living Donors | 17 | 2015 | 636 | 0.690 |
Why?
|
Lymph Nodes | 12 | 2015 | 3489 | 0.660 |
Why?
|
Humans | 364 | 2024 | 759255 | 0.640 |
Why?
|
Lymphatic Metastasis | 21 | 2015 | 2943 | 0.640 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7460 | 0.620 |
Why?
|
Combined Modality Therapy | 21 | 2023 | 8549 | 0.610 |
Why?
|
Meningeal Neoplasms | 2 | 2018 | 1245 | 0.600 |
Why?
|
Flucytosine | 2 | 2011 | 32 | 0.600 |
Why?
|
Camptothecin | 3 | 2017 | 588 | 0.580 |
Why?
|
Kidney Failure, Chronic | 9 | 2015 | 2469 | 0.570 |
Why?
|
Guanidines | 8 | 2000 | 193 | 0.560 |
Why?
|
Oxonic Acid | 2 | 2017 | 31 | 0.550 |
Why?
|
Tegafur | 2 | 2017 | 39 | 0.550 |
Why?
|
Mice, Inbred BALB C | 18 | 2019 | 6218 | 0.550 |
Why?
|
Prognosis | 46 | 2021 | 29561 | 0.540 |
Why?
|
Lymph Node Excision | 10 | 2015 | 1304 | 0.540 |
Why?
|
Animals | 115 | 2024 | 167838 | 0.540 |
Why?
|
Neoplasms | 21 | 2023 | 22019 | 0.530 |
Why?
|
Infection Control | 2 | 2020 | 983 | 0.530 |
Why?
|
Isoantibodies | 6 | 2015 | 661 | 0.520 |
Why?
|
Portal Vein | 5 | 2023 | 430 | 0.520 |
Why?
|
Neoplasm Recurrence, Local | 17 | 2020 | 9269 | 0.520 |
Why?
|
Male | 221 | 2024 | 358719 | 0.520 |
Why?
|
Disease Models, Animal | 26 | 2024 | 18110 | 0.520 |
Why?
|
Neoplasm Metastasis | 16 | 2021 | 4883 | 0.510 |
Why?
|
Pancreatic Neoplasms | 9 | 2024 | 5310 | 0.510 |
Why?
|
Arteritis | 1 | 2017 | 162 | 0.510 |
Why?
|
Diethylnitrosamine | 6 | 2024 | 45 | 0.510 |
Why?
|
Tunica Intima | 1 | 2017 | 459 | 0.510 |
Why?
|
Mice | 62 | 2024 | 81138 | 0.510 |
Why?
|
Carcinoma | 9 | 2003 | 2334 | 0.510 |
Why?
|
Tissue Donors | 20 | 2016 | 2301 | 0.490 |
Why?
|
Tumor Cells, Cultured | 27 | 2015 | 6131 | 0.480 |
Why?
|
Microvessels | 1 | 2019 | 572 | 0.480 |
Why?
|
Mice, Nude | 11 | 2024 | 3605 | 0.480 |
Why?
|
Postoperative Complications | 30 | 2022 | 15672 | 0.470 |
Why?
|
Survival Rate | 40 | 2019 | 12800 | 0.470 |
Why?
|
Esophagogastric Junction | 1 | 2016 | 343 | 0.470 |
Why?
|
Prodrugs | 4 | 2011 | 259 | 0.460 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3087 | 0.460 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3207 | 0.460 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 16 | 2024 | 11653 | 0.460 |
Why?
|
Disease Progression | 16 | 2022 | 13479 | 0.450 |
Why?
|
Breast Neoplasms | 15 | 2023 | 21022 | 0.450 |
Why?
|
Cytosine Deaminase | 2 | 2011 | 65 | 0.440 |
Why?
|
Manganese | 3 | 2022 | 393 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 26 | 2024 | 36160 | 0.430 |
Why?
|
Cell Line, Tumor | 23 | 2024 | 16871 | 0.430 |
Why?
|
Collagen | 8 | 2023 | 2635 | 0.410 |
Why?
|
Ulcer | 1 | 2014 | 205 | 0.410 |
Why?
|
Genetic Vectors | 9 | 2011 | 3377 | 0.410 |
Why?
|
Luminescent Measurements | 1 | 2014 | 377 | 0.410 |
Why?
|
Exercise Tolerance | 9 | 2007 | 815 | 0.410 |
Why?
|
Female | 191 | 2024 | 390240 | 0.400 |
Why?
|
CD40 Ligand | 1 | 2014 | 521 | 0.400 |
Why?
|
Fibrosis | 6 | 2024 | 2041 | 0.400 |
Why?
|
Plasma Cells | 1 | 2015 | 591 | 0.400 |
Why?
|
Rats | 34 | 2024 | 23694 | 0.400 |
Why?
|
Aldehydes | 2 | 2023 | 171 | 0.400 |
Why?
|
Kidney | 16 | 2017 | 7066 | 0.400 |
Why?
|
Hyaluronic Acid | 5 | 2007 | 482 | 0.400 |
Why?
|
Follow-Up Studies | 56 | 2020 | 39216 | 0.390 |
Why?
|
Middle Aged | 159 | 2024 | 219653 | 0.390 |
Why?
|
Organometallic Compounds | 5 | 2020 | 660 | 0.390 |
Why?
|
Positron-Emission Tomography | 7 | 2024 | 6436 | 0.390 |
Why?
|
Carcinoma, Pancreatic Ductal | 5 | 2024 | 1708 | 0.380 |
Why?
|
Esophageal Neoplasms | 4 | 2016 | 1655 | 0.380 |
Why?
|
Hepatitis C, Chronic | 6 | 2020 | 1030 | 0.370 |
Why?
|
Antineoplastic Agents | 18 | 2016 | 13621 | 0.370 |
Why?
|
Natural Killer T-Cells | 1 | 2014 | 309 | 0.360 |
Why?
|
HT29 Cells | 6 | 2014 | 190 | 0.360 |
Why?
|
Adenocarcinoma | 7 | 2023 | 6311 | 0.360 |
Why?
|
Desensitization, Immunologic | 1 | 2015 | 532 | 0.350 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3584 | 0.350 |
Why?
|
Vero Cells | 6 | 2014 | 484 | 0.350 |
Why?
|
Collagen Type I | 3 | 2024 | 615 | 0.350 |
Why?
|
Adult | 148 | 2022 | 219390 | 0.340 |
Why?
|
Contrast Media | 8 | 2023 | 5302 | 0.340 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2017 | 729 | 0.340 |
Why?
|
Protein Kinase Inhibitors | 6 | 2019 | 5635 | 0.330 |
Why?
|
Gadolinium | 6 | 2021 | 958 | 0.330 |
Why?
|
Ganciclovir | 3 | 2000 | 252 | 0.330 |
Why?
|
Peritoneal Neoplasms | 2 | 2022 | 706 | 0.330 |
Why?
|
Immunity, Cellular | 3 | 2011 | 1558 | 0.320 |
Why?
|
Transplantation Tolerance | 1 | 2014 | 605 | 0.320 |
Why?
|
Neoplasm Staging | 22 | 2019 | 11123 | 0.320 |
Why?
|
Neovascularization, Pathologic | 5 | 2013 | 2635 | 0.320 |
Why?
|
Time Factors | 59 | 2021 | 40109 | 0.320 |
Why?
|
Coordination Complexes | 2 | 2021 | 114 | 0.310 |
Why?
|
Leucovorin | 5 | 2024 | 629 | 0.310 |
Why?
|
Ribonucleosides | 8 | 2005 | 79 | 0.310 |
Why?
|
Neoplasm Invasiveness | 10 | 2019 | 3619 | 0.310 |
Why?
|
Thymidine Kinase | 3 | 2023 | 286 | 0.310 |
Why?
|
Retrospective Studies | 69 | 2023 | 80121 | 0.310 |
Why?
|
Histocompatibility Testing | 17 | 2008 | 717 | 0.300 |
Why?
|
Rats, Wistar | 9 | 2020 | 1849 | 0.300 |
Why?
|
Cyclosporins | 9 | 1992 | 216 | 0.300 |
Why?
|
Chemotherapy, Adjuvant | 9 | 2023 | 3519 | 0.300 |
Why?
|
Transgenes | 4 | 2012 | 1006 | 0.290 |
Why?
|
Molecular Targeted Therapy | 4 | 2019 | 2803 | 0.290 |
Why?
|
Biopsy | 16 | 2020 | 6772 | 0.280 |
Why?
|
Electrocoagulation | 3 | 2007 | 153 | 0.280 |
Why?
|
Aged | 97 | 2024 | 168617 | 0.270 |
Why?
|
Azathioprine | 11 | 2000 | 356 | 0.270 |
Why?
|
Anaerobic Threshold | 4 | 1994 | 52 | 0.270 |
Why?
|
Survival Analysis | 16 | 2020 | 10185 | 0.270 |
Why?
|
Peptide Fragments | 8 | 2007 | 5120 | 0.270 |
Why?
|
Oncogenic Viruses | 2 | 2002 | 37 | 0.260 |
Why?
|
Plasmapheresis | 6 | 2011 | 206 | 0.260 |
Why?
|
Cytochrome P-450 CYP2B1 | 2 | 2002 | 21 | 0.260 |
Why?
|
Peritoneum | 1 | 2006 | 225 | 0.260 |
Why?
|
Europe | 3 | 2021 | 3429 | 0.260 |
Why?
|
Transplantation Immunology | 4 | 2007 | 532 | 0.250 |
Why?
|
Antigens, Neoplasm | 2 | 2004 | 1997 | 0.250 |
Why?
|
Magnesium | 3 | 1998 | 810 | 0.250 |
Why?
|
Intestinal Absorption | 2 | 2000 | 401 | 0.250 |
Why?
|
Treatment Outcome | 39 | 2024 | 64879 | 0.250 |
Why?
|
Receptors, Lymphocyte Homing | 3 | 1995 | 142 | 0.250 |
Why?
|
Thioacetamide | 1 | 2024 | 22 | 0.250 |
Why?
|
Gallbladder Neoplasms | 3 | 2011 | 191 | 0.250 |
Why?
|
Transplantation, Homologous | 12 | 2016 | 4799 | 0.240 |
Why?
|
Neoadjuvant Therapy | 6 | 2024 | 2809 | 0.240 |
Why?
|
Catheter Ablation | 5 | 2019 | 2749 | 0.240 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 2 | 2009 | 92 | 0.240 |
Why?
|
Vaccinia virus | 2 | 2003 | 332 | 0.240 |
Why?
|
Thorium Dioxide | 1 | 2004 | 20 | 0.230 |
Why?
|
Glycoproteins | 2 | 2010 | 2203 | 0.230 |
Why?
|
Ribonucleotide Reductases | 2 | 2002 | 76 | 0.230 |
Why?
|
Methylprednisolone | 12 | 2002 | 384 | 0.230 |
Why?
|
DNA Methylation | 1 | 2018 | 4371 | 0.230 |
Why?
|
Oligonucleotides, Antisense | 1 | 2006 | 460 | 0.230 |
Why?
|
2-Aminoadipic Acid | 1 | 2023 | 33 | 0.220 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2015 | 922 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2021 | 8491 | 0.220 |
Why?
|
Antigens, CD | 4 | 2013 | 4000 | 0.220 |
Why?
|
Polymerase Chain Reaction | 12 | 2016 | 6070 | 0.220 |
Why?
|
Drug Discovery | 3 | 2021 | 1054 | 0.210 |
Why?
|
Adenoviridae | 3 | 2003 | 1084 | 0.210 |
Why?
|
Interferon-alpha | 6 | 2014 | 918 | 0.210 |
Why?
|
Liver Transplantation | 5 | 2018 | 2313 | 0.200 |
Why?
|
Cytomegalovirus Infections | 3 | 1998 | 832 | 0.200 |
Why?
|
Heart Transplantation | 2 | 2014 | 3214 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2016 | 15750 | 0.200 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3694 | 0.200 |
Why?
|
Alternative Splicing | 6 | 2000 | 1091 | 0.200 |
Why?
|
Indocyanine Green | 1 | 2023 | 235 | 0.200 |
Why?
|
Antibodies, Monoclonal | 10 | 2015 | 9194 | 0.200 |
Why?
|
Captopril | 1 | 2022 | 266 | 0.200 |
Why?
|
Nucleoside Deaminases | 1 | 2001 | 58 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2009 | 1408 | 0.190 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2021 | 46 | 0.190 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9374 | 0.190 |
Why?
|
Mice, Inbred Strains | 3 | 2014 | 1766 | 0.190 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2002 | 619 | 0.190 |
Why?
|
Magnetite Nanoparticles | 1 | 2023 | 315 | 0.190 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2007 | 614 | 0.190 |
Why?
|
B-Lymphocytes | 4 | 2011 | 4733 | 0.190 |
Why?
|
Heart Diseases | 2 | 2014 | 2800 | 0.190 |
Why?
|
Hepatitis B, Chronic | 1 | 2005 | 402 | 0.190 |
Why?
|
Spleen | 2 | 2005 | 2297 | 0.180 |
Why?
|
Drug Therapy, Combination | 17 | 2005 | 6496 | 0.180 |
Why?
|
Tooth | 2 | 2013 | 208 | 0.180 |
Why?
|
Sleep Deprivation | 2 | 1998 | 840 | 0.180 |
Why?
|
Adolescent | 59 | 2015 | 87560 | 0.180 |
Why?
|
Aged, 80 and over | 35 | 2021 | 58867 | 0.180 |
Why?
|
Schistosomiasis mansoni | 1 | 2021 | 94 | 0.180 |
Why?
|
Bile Acids and Salts | 1 | 2022 | 380 | 0.180 |
Why?
|
Disease-Free Survival | 9 | 2020 | 6813 | 0.180 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2002 | 438 | 0.180 |
Why?
|
Peptides | 4 | 2020 | 4357 | 0.170 |
Why?
|
Catechin | 1 | 2020 | 69 | 0.170 |
Why?
|
Prednisolone | 1 | 2021 | 328 | 0.170 |
Why?
|
Manganese Compounds | 1 | 2019 | 25 | 0.170 |
Why?
|
Japan | 9 | 2005 | 1367 | 0.170 |
Why?
|
Biopsy, Needle | 6 | 2016 | 1633 | 0.170 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2004 | 549 | 0.170 |
Why?
|
Convalescence | 1 | 2020 | 106 | 0.170 |
Why?
|
Diamines | 1 | 2019 | 59 | 0.170 |
Why?
|
Picolinic Acids | 1 | 2019 | 51 | 0.170 |
Why?
|
Extracellular Matrix Proteins | 2 | 2022 | 829 | 0.170 |
Why?
|
Vimentin | 4 | 2017 | 255 | 0.170 |
Why?
|
Genetic Engineering | 7 | 2005 | 932 | 0.170 |
Why?
|
Drug Administration Schedule | 3 | 2015 | 4898 | 0.170 |
Why?
|
Cyclophosphamide | 2 | 2002 | 2218 | 0.170 |
Why?
|
Mice, Inbred C57BL | 10 | 2024 | 21981 | 0.160 |
Why?
|
Mucin-1 | 1 | 2004 | 539 | 0.160 |
Why?
|
Gelatinases | 1 | 1999 | 88 | 0.160 |
Why?
|
Lung Neoplasms | 10 | 2015 | 13238 | 0.160 |
Why?
|
STAT3 Transcription Factor | 2 | 2017 | 872 | 0.160 |
Why?
|
Viruses | 2 | 2002 | 376 | 0.160 |
Why?
|
6-Ketoprostaglandin F1 alpha | 3 | 1997 | 80 | 0.160 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2018 | 72 | 0.160 |
Why?
|
Thromboxane B2 | 3 | 1997 | 147 | 0.160 |
Why?
|
Biliary Tract Neoplasms | 1 | 2020 | 185 | 0.160 |
Why?
|
HTLV-I Infections | 1 | 1998 | 103 | 0.160 |
Why?
|
Anticarcinogenic Agents | 1 | 2020 | 249 | 0.150 |
Why?
|
Manuscripts as Topic | 1 | 2018 | 15 | 0.150 |
Why?
|
Piperazines | 3 | 2007 | 2517 | 0.150 |
Why?
|
Antimetabolites | 1 | 1998 | 127 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2019 | 5214 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 206 | 0.150 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 854 | 0.150 |
Why?
|
Viral Proteins | 2 | 2002 | 1803 | 0.150 |
Why?
|
Pneumonia, Pneumocystis | 2 | 1991 | 245 | 0.150 |
Why?
|
Palliative Care | 3 | 2020 | 3606 | 0.150 |
Why?
|
Blood Transfusion | 3 | 1996 | 1327 | 0.150 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2007 | 2416 | 0.150 |
Why?
|
Transplantation Chimera | 3 | 2014 | 595 | 0.150 |
Why?
|
Creatinine | 13 | 2000 | 1907 | 0.150 |
Why?
|
Blotting, Western | 9 | 2016 | 5039 | 0.150 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 8 | 2016 | 3804 | 0.150 |
Why?
|
Thrombosis | 2 | 2023 | 3043 | 0.150 |
Why?
|
Transfection | 9 | 2006 | 5783 | 0.150 |
Why?
|
Liver Failure | 2 | 2019 | 249 | 0.150 |
Why?
|
Child | 45 | 2015 | 79623 | 0.150 |
Why?
|
Disulfiram | 1 | 2017 | 62 | 0.140 |
Why?
|
Muromonab-CD3 | 2 | 2000 | 104 | 0.140 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2005 | 937 | 0.140 |
Why?
|
Gibberellins | 1 | 2016 | 8 | 0.140 |
Why?
|
Pyrus | 1 | 2016 | 13 | 0.140 |
Why?
|
Fibrin | 1 | 2020 | 505 | 0.140 |
Why?
|
Drug Combinations | 4 | 2018 | 2023 | 0.140 |
Why?
|
Cause of Death | 7 | 2019 | 3721 | 0.140 |
Why?
|
Angiogenesis Inhibitors | 2 | 2006 | 2048 | 0.140 |
Why?
|
Cilazapril | 1 | 1996 | 3 | 0.140 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 1040 | 0.140 |
Why?
|
Metalloendopeptidases | 1 | 1999 | 394 | 0.140 |
Why?
|
Ureteral Obstruction | 1 | 2019 | 292 | 0.140 |
Why?
|
Physical Exertion | 1 | 2020 | 662 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 12 | 2021 | 20461 | 0.140 |
Why?
|
Extracellular Matrix | 4 | 2023 | 1726 | 0.140 |
Why?
|
Chelating Agents | 1 | 2018 | 384 | 0.140 |
Why?
|
Gliosarcoma | 1 | 1997 | 113 | 0.140 |
Why?
|
Immunohistochemistry | 11 | 2016 | 11058 | 0.140 |
Why?
|
Plant Growth Regulators | 1 | 2016 | 50 | 0.140 |
Why?
|
Pyrimidines | 2 | 2019 | 2996 | 0.140 |
Why?
|
Lipogenesis | 1 | 2018 | 209 | 0.140 |
Why?
|
Frizzled Receptors | 1 | 2017 | 90 | 0.140 |
Why?
|
Injections, Intravenous | 3 | 2008 | 1388 | 0.140 |
Why?
|
Catecholamines | 2 | 1996 | 385 | 0.140 |
Why?
|
Keratan Sulfate | 1 | 1996 | 17 | 0.140 |
Why?
|
Haplorhini | 4 | 2008 | 529 | 0.140 |
Why?
|
Radiopharmaceuticals | 8 | 2024 | 2630 | 0.140 |
Why?
|
Ligation | 2 | 2015 | 449 | 0.140 |
Why?
|
Epitopes | 2 | 2000 | 2506 | 0.140 |
Why?
|
Organophosphorus Compounds | 2 | 2016 | 202 | 0.140 |
Why?
|
Genes, p53 | 1 | 1999 | 714 | 0.130 |
Why?
|
Macrophages | 5 | 2022 | 5730 | 0.130 |
Why?
|
Hepatocytes | 3 | 2024 | 1228 | 0.130 |
Why?
|
Cancer Care Facilities | 1 | 2019 | 424 | 0.130 |
Why?
|
Diagnostic Imaging | 2 | 2010 | 3526 | 0.130 |
Why?
|
Graft Enhancement, Immunologic | 1 | 1996 | 57 | 0.130 |
Why?
|
Bile Ducts | 2 | 2015 | 284 | 0.130 |
Why?
|
Molecular Probes | 4 | 2022 | 312 | 0.130 |
Why?
|
Cells, Cultured | 14 | 2015 | 18968 | 0.130 |
Why?
|
Glycoside Hydrolases | 1 | 1996 | 132 | 0.130 |
Why?
|
Writing | 1 | 2018 | 199 | 0.130 |
Why?
|
Pandemics | 3 | 2020 | 8609 | 0.130 |
Why?
|
Dendritic Cells | 2 | 2006 | 2725 | 0.130 |
Why?
|
Cell Adhesion | 7 | 2007 | 3094 | 0.130 |
Why?
|
Hospitals, General | 1 | 2020 | 795 | 0.130 |
Why?
|
Desmin | 2 | 2010 | 99 | 0.130 |
Why?
|
Kidney Function Tests | 3 | 2015 | 680 | 0.130 |
Why?
|
Ceramides | 1 | 2017 | 200 | 0.130 |
Why?
|
Phosphoprotein Phosphatases | 3 | 2004 | 330 | 0.130 |
Why?
|
Antigens, Viral | 2 | 1997 | 980 | 0.130 |
Why?
|
Lymphocytes | 3 | 2020 | 2609 | 0.130 |
Why?
|
Liver Circulation | 2 | 2008 | 159 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2020 | 951 | 0.130 |
Why?
|
Risk Factors | 25 | 2020 | 74167 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2015 | 1354 | 0.130 |
Why?
|
Ischemia | 1 | 2024 | 1893 | 0.120 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 2015 | 29 | 0.120 |
Why?
|
Reactive Oxygen Species | 2 | 2022 | 2135 | 0.120 |
Why?
|
Cadherins | 4 | 2017 | 898 | 0.120 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2010 | 550 | 0.120 |
Why?
|
Photons | 1 | 2019 | 580 | 0.120 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2017 | 432 | 0.120 |
Why?
|
Journal Impact Factor | 1 | 2016 | 156 | 0.120 |
Why?
|
Polysaccharides, Bacterial | 1 | 2017 | 574 | 0.120 |
Why?
|
Thromboxane-A Synthase | 3 | 1989 | 34 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 2 | 2016 | 389 | 0.120 |
Why?
|
Models, Biological | 5 | 2021 | 9466 | 0.120 |
Why?
|
Kidney Glomerulus | 4 | 2007 | 568 | 0.120 |
Why?
|
Melanoma, Amelanotic | 1 | 2014 | 19 | 0.120 |
Why?
|
Promoter Regions, Genetic | 2 | 2004 | 5789 | 0.120 |
Why?
|
Tumor Burden | 5 | 2017 | 1886 | 0.120 |
Why?
|
High-Throughput Screening Assays | 2 | 2017 | 943 | 0.120 |
Why?
|
Antibody Specificity | 2 | 2015 | 1061 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2022 | 1521 | 0.120 |
Why?
|
Lysophospholipids | 1 | 2016 | 339 | 0.120 |
Why?
|
Hepacivirus | 3 | 2021 | 1332 | 0.120 |
Why?
|
Splenectomy | 2 | 2011 | 391 | 0.120 |
Why?
|
Hepatitis B virus | 2 | 2010 | 517 | 0.120 |
Why?
|
Recombinant Proteins | 7 | 2014 | 6542 | 0.120 |
Why?
|
Cell Proliferation | 7 | 2018 | 10440 | 0.120 |
Why?
|
Neoplasm Transplantation | 4 | 2005 | 2015 | 0.110 |
Why?
|
Prospective Studies | 14 | 2020 | 54204 | 0.110 |
Why?
|
Biomimetics | 1 | 2015 | 175 | 0.110 |
Why?
|
Steroids | 1 | 2019 | 928 | 0.110 |
Why?
|
Galactosylceramides | 1 | 2014 | 92 | 0.110 |
Why?
|
Complement C4b | 3 | 2007 | 132 | 0.110 |
Why?
|
Mice, Inbred C3H | 2 | 2014 | 915 | 0.110 |
Why?
|
Chronic Disease | 13 | 2011 | 9282 | 0.110 |
Why?
|
Lipase | 1 | 2016 | 324 | 0.110 |
Why?
|
Plasmodium falciparum | 4 | 2000 | 1741 | 0.110 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2218 | 0.110 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5880 | 0.110 |
Why?
|
Neuroleptic Malignant Syndrome | 1 | 1994 | 74 | 0.110 |
Why?
|
Clinical Trials as Topic | 7 | 2019 | 8055 | 0.110 |
Why?
|
Organ Transplantation | 2 | 2020 | 1150 | 0.110 |
Why?
|
Androgens | 1 | 2021 | 1288 | 0.110 |
Why?
|
Organoplatinum Compounds | 2 | 2017 | 409 | 0.110 |
Why?
|
Pancreas | 1 | 2020 | 1677 | 0.110 |
Why?
|
Cell Division | 9 | 2003 | 4463 | 0.110 |
Why?
|
Sputum | 2 | 1993 | 502 | 0.110 |
Why?
|
New Zealand | 1 | 2014 | 354 | 0.110 |
Why?
|
Fatty Acids, Monounsaturated | 2 | 1997 | 190 | 0.110 |
Why?
|
Pentetic Acid | 1 | 1993 | 209 | 0.110 |
Why?
|
Apoptosis | 10 | 2014 | 9492 | 0.110 |
Why?
|
Tissue Distribution | 4 | 2019 | 2262 | 0.110 |
Why?
|
Cadaver | 7 | 2008 | 1344 | 0.110 |
Why?
|
Membrane Proteins | 6 | 2016 | 7851 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1994 | 0.110 |
Why?
|
Cisplatin | 2 | 2017 | 1642 | 0.100 |
Why?
|
Myocardial Infarction | 7 | 1996 | 11888 | 0.100 |
Why?
|
Nevus | 1 | 2014 | 205 | 0.100 |
Why?
|
Kidney Diseases | 3 | 2019 | 2092 | 0.100 |
Why?
|
Hyaluronoglucosaminidase | 1 | 1993 | 135 | 0.100 |
Why?
|
Immunotherapy | 6 | 2019 | 4622 | 0.100 |
Why?
|
Sex Factors | 6 | 2020 | 10518 | 0.100 |
Why?
|
Asia | 1 | 2014 | 618 | 0.100 |
Why?
|
Thiazolidinediones | 2 | 2009 | 465 | 0.100 |
Why?
|
Tooth Root | 1 | 2013 | 162 | 0.100 |
Why?
|
Transcriptional Activation | 2 | 2022 | 1756 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2003 | 886 | 0.100 |
Why?
|
Perfusion Imaging | 1 | 2013 | 196 | 0.100 |
Why?
|
Glutarates | 1 | 2014 | 244 | 0.100 |
Why?
|
Hemodynamics | 4 | 1997 | 4164 | 0.100 |
Why?
|
Neoplasm Proteins | 5 | 2006 | 3613 | 0.100 |
Why?
|
Age Distribution | 3 | 2007 | 2892 | 0.100 |
Why?
|
Lupus Nephritis | 1 | 2015 | 318 | 0.100 |
Why?
|
Communicable Diseases | 2 | 1998 | 879 | 0.100 |
Why?
|
Molecular Sequence Data | 14 | 2000 | 17629 | 0.100 |
Why?
|
Erythrocytes | 3 | 1998 | 2416 | 0.100 |
Why?
|
Myocardial Reperfusion | 1 | 1993 | 347 | 0.100 |
Why?
|
Liver Diseases | 1 | 2020 | 1297 | 0.100 |
Why?
|
Periodontal Ligament | 2 | 2003 | 117 | 0.100 |
Why?
|
DNA, Protozoan | 1 | 1992 | 228 | 0.100 |
Why?
|
Acute Disease | 5 | 2017 | 7262 | 0.100 |
Why?
|
Nanoparticles | 1 | 2023 | 1935 | 0.100 |
Why?
|
Risk Assessment | 9 | 2012 | 24049 | 0.100 |
Why?
|
Pentamidine | 1 | 1991 | 44 | 0.100 |
Why?
|
Axilla | 1 | 2014 | 617 | 0.090 |
Why?
|
Kidney Tubules | 4 | 2007 | 449 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1395 | 0.090 |
Why?
|
Sex Distribution | 2 | 2007 | 2294 | 0.090 |
Why?
|
Nucleic Acid Hybridization | 2 | 1992 | 1304 | 0.090 |
Why?
|
Interleukins | 1 | 2016 | 780 | 0.090 |
Why?
|
Fruit | 1 | 2016 | 1162 | 0.090 |
Why?
|
Blood Grouping and Crossmatching | 3 | 1996 | 100 | 0.090 |
Why?
|
Pulmonary Gas Exchange | 1 | 1993 | 378 | 0.090 |
Why?
|
Complement C4 | 2 | 2004 | 244 | 0.090 |
Why?
|
Child, Preschool | 19 | 2012 | 41935 | 0.090 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2015 | 664 | 0.090 |
Why?
|
Antigens, CD20 | 1 | 2011 | 201 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2015 | 10827 | 0.090 |
Why?
|
Carrier Proteins | 4 | 2007 | 4939 | 0.090 |
Why?
|
Basophils | 1 | 1993 | 405 | 0.090 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 11908 | 0.090 |
Why?
|
Yeasts | 1 | 2011 | 279 | 0.090 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 586 | 0.090 |
Why?
|
Mutation | 11 | 2019 | 29877 | 0.090 |
Why?
|
Renal Dialysis | 2 | 1998 | 1802 | 0.090 |
Why?
|
DNA Primers | 4 | 2001 | 2817 | 0.090 |
Why?
|
Publishing | 1 | 2018 | 837 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1785 | 0.090 |
Why?
|
Necrosis | 4 | 2009 | 1613 | 0.090 |
Why?
|
Case-Control Studies | 8 | 2013 | 21988 | 0.090 |
Why?
|
Cholelithiasis | 1 | 2011 | 410 | 0.090 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 2002 | 151 | 0.090 |
Why?
|
Liposomes | 1 | 2014 | 776 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2309 | 0.090 |
Why?
|
Polyps | 1 | 2011 | 198 | 0.090 |
Why?
|
Mammography | 3 | 2006 | 2449 | 0.090 |
Why?
|
Australia | 1 | 2014 | 1287 | 0.090 |
Why?
|
Medical History Taking | 1 | 2014 | 773 | 0.090 |
Why?
|
Incidence | 11 | 2019 | 21336 | 0.090 |
Why?
|
Cancer Vaccines | 3 | 2003 | 1044 | 0.090 |
Why?
|
Antibodies | 3 | 1997 | 2423 | 0.090 |
Why?
|
Benchmarking | 1 | 2016 | 1040 | 0.080 |
Why?
|
Base Sequence | 8 | 2000 | 12450 | 0.080 |
Why?
|
Patient Care Team | 2 | 2020 | 2510 | 0.080 |
Why?
|
Chemoprevention | 2 | 2022 | 326 | 0.080 |
Why?
|
Tissue and Organ Procurement | 1 | 1998 | 941 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2016 | 2824 | 0.080 |
Why?
|
Long-Term Care | 1 | 2014 | 628 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3810 | 0.080 |
Why?
|
Oral Surgical Procedures | 1 | 2011 | 166 | 0.080 |
Why?
|
Phosphorylation | 5 | 2018 | 8313 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1344 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2018 | 3150 | 0.080 |
Why?
|
T-Lymphocytes | 8 | 2017 | 10181 | 0.080 |
Why?
|
Acyclovir | 1 | 1990 | 269 | 0.080 |
Why?
|
Medical Oncology | 2 | 2019 | 2311 | 0.080 |
Why?
|
Radionuclide Imaging | 6 | 2003 | 1975 | 0.080 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 1659 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15264 | 0.080 |
Why?
|
Lethal Dose 50 | 1 | 2008 | 72 | 0.080 |
Why?
|
Antiviral Agents | 5 | 2016 | 3060 | 0.080 |
Why?
|
Ischemic Preconditioning | 1 | 2009 | 89 | 0.080 |
Why?
|
Reference Values | 5 | 2016 | 4918 | 0.080 |
Why?
|
Pathology, Clinical | 1 | 2012 | 375 | 0.080 |
Why?
|
Melanocytes | 1 | 2012 | 511 | 0.080 |
Why?
|
Down-Regulation | 3 | 2010 | 2920 | 0.080 |
Why?
|
Image Enhancement | 1 | 2019 | 2878 | 0.080 |
Why?
|
Heterocyclic Compounds | 2 | 2020 | 247 | 0.080 |
Why?
|
Colon | 2 | 1995 | 1791 | 0.080 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 691 | 0.080 |
Why?
|
Extremities | 1 | 1994 | 864 | 0.080 |
Why?
|
Inflammation | 4 | 2021 | 10747 | 0.080 |
Why?
|
Sulfamethoxazole | 1 | 1988 | 54 | 0.080 |
Why?
|
Treatment Failure | 5 | 2019 | 2642 | 0.080 |
Why?
|
Young Adult | 12 | 2016 | 58483 | 0.080 |
Why?
|
Canada | 1 | 2014 | 2124 | 0.080 |
Why?
|
Glomerulonephritis, IGA | 2 | 2000 | 62 | 0.080 |
Why?
|
Up-Regulation | 3 | 2010 | 4132 | 0.080 |
Why?
|
Ultrasonography | 5 | 2011 | 5955 | 0.080 |
Why?
|
Injections, Intraperitoneal | 1 | 2008 | 413 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1614 | 0.080 |
Why?
|
Capillaries | 3 | 2007 | 744 | 0.080 |
Why?
|
Trimethoprim | 1 | 1988 | 85 | 0.080 |
Why?
|
Metformin | 1 | 2016 | 912 | 0.080 |
Why?
|
Random Allocation | 3 | 2017 | 2393 | 0.080 |
Why?
|
Cell Cycle | 2 | 1995 | 2939 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 1990 | 1547 | 0.080 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2010 | 221 | 0.080 |
Why?
|
Caspases | 3 | 2006 | 878 | 0.080 |
Why?
|
Genotype | 6 | 2017 | 12940 | 0.070 |
Why?
|
Sirolimus | 1 | 2015 | 1548 | 0.070 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 640 | 0.070 |
Why?
|
Preoperative Care | 4 | 2004 | 2256 | 0.070 |
Why?
|
Receptors, Cell Surface | 2 | 1995 | 2822 | 0.070 |
Why?
|
Radiosurgery | 1 | 2017 | 1341 | 0.070 |
Why?
|
DNA, Neoplasm | 4 | 1999 | 1744 | 0.070 |
Why?
|
Cell Culture Techniques | 1 | 2015 | 1666 | 0.070 |
Why?
|
Gabexate | 1 | 1987 | 12 | 0.070 |
Why?
|
Multicenter Studies as Topic | 2 | 2010 | 1719 | 0.070 |
Why?
|
alpha-Cyclodextrins | 1 | 1987 | 12 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3767 | 0.070 |
Why?
|
Integrin alpha6beta1 | 1 | 2006 | 19 | 0.070 |
Why?
|
Immunogenetics | 1 | 2007 | 66 | 0.070 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 749 | 0.070 |
Why?
|
Exercise | 4 | 2020 | 5773 | 0.070 |
Why?
|
Oxygen Consumption | 8 | 1997 | 1840 | 0.070 |
Why?
|
Urinary Tract Infections | 4 | 1997 | 816 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2168 | 0.070 |
Why?
|
Respiration | 1 | 2013 | 1648 | 0.070 |
Why?
|
Basement Membrane | 2 | 2007 | 348 | 0.070 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2017 | 345 | 0.070 |
Why?
|
Heart Rate | 8 | 1998 | 4165 | 0.070 |
Why?
|
Glutamine | 2 | 2002 | 576 | 0.070 |
Why?
|
Cell Adhesion Molecules | 1 | 1993 | 1600 | 0.070 |
Why?
|
Collagen Type III | 1 | 2006 | 91 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2021 | 6532 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3920 | 0.070 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2008 | 268 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3754 | 0.070 |
Why?
|
Mohs Surgery | 1 | 2009 | 221 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2006 | 3478 | 0.070 |
Why?
|
Actuarial Analysis | 2 | 1998 | 375 | 0.070 |
Why?
|
Cell Growth Processes | 1 | 2007 | 384 | 0.070 |
Why?
|
Sclerosis | 1 | 2006 | 210 | 0.070 |
Why?
|
United States | 6 | 2021 | 72237 | 0.070 |
Why?
|
Mice, Inbred ICR | 1 | 2006 | 363 | 0.070 |
Why?
|
Methotrexate | 1 | 2013 | 1714 | 0.070 |
Why?
|
Drug Resistance | 1 | 1992 | 1611 | 0.070 |
Why?
|
Phenylurea Compounds | 2 | 2019 | 529 | 0.070 |
Why?
|
Half-Life | 3 | 2017 | 652 | 0.070 |
Why?
|
Patient Selection | 4 | 2008 | 4269 | 0.070 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2001 | 325 | 0.070 |
Why?
|
Guanine | 1 | 2007 | 278 | 0.060 |
Why?
|
Drug Resistance, Multiple | 1 | 2007 | 254 | 0.060 |
Why?
|
Salivary Glands | 1 | 2007 | 228 | 0.060 |
Why?
|
Immunoglobulin A | 2 | 2007 | 975 | 0.060 |
Why?
|
Blood Stains | 2 | 1996 | 8 | 0.060 |
Why?
|
Receptor, IGF Type 1 | 1 | 2008 | 380 | 0.060 |
Why?
|
Angiogenic Proteins | 1 | 2006 | 101 | 0.060 |
Why?
|
Amino Acid Sequence | 10 | 2000 | 13456 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2011 | 12964 | 0.060 |
Why?
|
Rectum | 1 | 1990 | 896 | 0.060 |
Why?
|
Gene Transfer, Horizontal | 1 | 2006 | 144 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2010 | 1655 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2014 | 10333 | 0.060 |
Why?
|
Multivariate Analysis | 4 | 2021 | 12152 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1469 | 0.060 |
Why?
|
Mass Screening | 3 | 2006 | 5419 | 0.060 |
Why?
|
Allantois | 1 | 2004 | 33 | 0.060 |
Why?
|
Postoperative Period | 5 | 2020 | 1823 | 0.060 |
Why?
|
Morbidity | 2 | 2007 | 1764 | 0.060 |
Why?
|
Mesoderm | 1 | 2008 | 672 | 0.060 |
Why?
|
Hospitals, Veterans | 1 | 2007 | 398 | 0.060 |
Why?
|
Spectrometry, Fluorescence | 1 | 1987 | 687 | 0.060 |
Why?
|
Gastroesophageal Reflux | 2 | 2009 | 817 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 1996 | 3143 | 0.060 |
Why?
|
Antibody Formation | 3 | 2004 | 1398 | 0.060 |
Why?
|
HLA Antigens | 3 | 2007 | 1366 | 0.060 |
Why?
|
Administration, Oral | 3 | 2000 | 4046 | 0.060 |
Why?
|
Cells | 1 | 2006 | 163 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2008 | 2448 | 0.060 |
Why?
|
Dogs | 4 | 1994 | 3838 | 0.060 |
Why?
|
Chorion | 1 | 2004 | 114 | 0.060 |
Why?
|
Radiotherapy Dosage | 3 | 2018 | 2895 | 0.060 |
Why?
|
Autophagy | 3 | 2009 | 1336 | 0.060 |
Why?
|
Fluorine Radioisotopes | 1 | 2007 | 413 | 0.060 |
Why?
|
NF-kappa B | 1 | 2013 | 2486 | 0.060 |
Why?
|
Lamivudine | 1 | 2005 | 363 | 0.060 |
Why?
|
Gene Expression | 2 | 2015 | 7593 | 0.060 |
Why?
|
Glass Ionomer Cements | 1 | 2003 | 17 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2852 | 0.060 |
Why?
|
Gallium Radioisotopes | 1 | 2024 | 194 | 0.060 |
Why?
|
Root Canal Filling Materials | 1 | 2003 | 29 | 0.060 |
Why?
|
DNA, Viral | 3 | 2002 | 2195 | 0.060 |
Why?
|
RNA, Messenger | 7 | 2015 | 12774 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2918 | 0.060 |
Why?
|
Physical Conditioning, Animal | 1 | 2007 | 366 | 0.060 |
Why?
|
Signal Transduction | 8 | 2021 | 23362 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2015 | 4545 | 0.060 |
Why?
|
Enzyme Induction | 3 | 1999 | 452 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 5 | 2007 | 2474 | 0.060 |
Why?
|
Immunoblotting | 1 | 2006 | 1649 | 0.060 |
Why?
|
Massachusetts | 4 | 2021 | 8788 | 0.060 |
Why?
|
Gadolinium DTPA | 2 | 2019 | 826 | 0.050 |
Why?
|
Mesenteric Veins | 1 | 2023 | 83 | 0.050 |
Why?
|
Anus Neoplasms | 1 | 2007 | 329 | 0.050 |
Why?
|
Nephrotic Syndrome | 1 | 2007 | 391 | 0.050 |
Why?
|
Epoprostenol | 4 | 1988 | 248 | 0.050 |
Why?
|
Tenascin | 1 | 2023 | 62 | 0.050 |
Why?
|
Fluorescence | 2 | 2023 | 750 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2019 | 3087 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 1996 | 514 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2004 | 186 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2015 | 1695 | 0.050 |
Why?
|
Probability | 2 | 2005 | 2475 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2021 | 3468 | 0.050 |
Why?
|
Immune Tolerance | 2 | 2006 | 2298 | 0.050 |
Why?
|
Pyridines | 2 | 2019 | 2875 | 0.050 |
Why?
|
Stem Cells | 1 | 2016 | 3525 | 0.050 |
Why?
|
Newcastle disease virus | 1 | 2002 | 21 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 1997 | 2940 | 0.050 |
Why?
|
Interferons | 3 | 2016 | 705 | 0.050 |
Why?
|
Sarcoma | 1 | 1994 | 1786 | 0.050 |
Why?
|
Saliva | 1 | 2007 | 816 | 0.050 |
Why?
|
Clostridium Infections | 1 | 1989 | 557 | 0.050 |
Why?
|
Transplantation, Autologous | 4 | 2013 | 2120 | 0.050 |
Why?
|
Kinetics | 4 | 2018 | 6380 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4573 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4360 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5317 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1149 | 0.050 |
Why?
|
Prostaglandins | 2 | 1997 | 398 | 0.050 |
Why?
|
Proteins | 4 | 2006 | 6029 | 0.050 |
Why?
|
Molecular Weight | 7 | 1995 | 2186 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2011 | 1588 | 0.050 |
Why?
|
Chickens | 1 | 2004 | 858 | 0.050 |
Why?
|
Autoantigens | 1 | 2006 | 877 | 0.050 |
Why?
|
Fatty Acids | 1 | 1990 | 1805 | 0.050 |
Why?
|
Cell Movement | 4 | 2017 | 5209 | 0.050 |
Why?
|
Teratoma | 1 | 2005 | 404 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3416 | 0.050 |
Why?
|
Nizatidine | 1 | 2021 | 7 | 0.050 |
Why?
|
DNA Nucleotidyltransferases | 3 | 1982 | 176 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2007 | 0.050 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2005 | 618 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2008 | 3604 | 0.050 |
Why?
|
Sialoglycoproteins | 2 | 2003 | 315 | 0.050 |
Why?
|
Delirium | 1 | 1994 | 1653 | 0.050 |
Why?
|
Reoviridae | 1 | 2002 | 162 | 0.050 |
Why?
|
Protein Folding | 1 | 2006 | 867 | 0.050 |
Why?
|
Micelles | 1 | 2022 | 192 | 0.050 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2005 | 329 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3095 | 0.050 |
Why?
|
Proportional Hazards Models | 6 | 2019 | 12522 | 0.050 |
Why?
|
Exercise Test | 4 | 2007 | 2124 | 0.050 |
Why?
|
Intraoperative Care | 3 | 2004 | 768 | 0.050 |
Why?
|
Vascular Diseases | 2 | 1987 | 1180 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 903 | 0.050 |
Why?
|
Receptors, Progesterone | 1 | 2006 | 1122 | 0.050 |
Why?
|
Benzamides | 1 | 2007 | 1369 | 0.050 |
Why?
|
Carcinoembryonic Antigen | 1 | 2002 | 336 | 0.050 |
Why?
|
HeLa Cells | 3 | 2000 | 3107 | 0.050 |
Why?
|
Age Factors | 8 | 2021 | 18394 | 0.050 |
Why?
|
Cysteine Endopeptidases | 2 | 2001 | 548 | 0.050 |
Why?
|
Logistic Models | 3 | 2011 | 13309 | 0.050 |
Why?
|
Chromans | 1 | 2001 | 117 | 0.050 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2002 | 185 | 0.050 |
Why?
|
Immunologic Surveillance | 1 | 2021 | 92 | 0.050 |
Why?
|
Rats, Inbred Lew | 2 | 1996 | 1154 | 0.050 |
Why?
|
Fever | 3 | 2001 | 1619 | 0.050 |
Why?
|
Cell Death | 2 | 2006 | 1669 | 0.050 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 1999 | 357 | 0.050 |
Why?
|
Coloring Agents | 3 | 2001 | 561 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4353 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2001 | 189 | 0.050 |
Why?
|
Retreatment | 2 | 2016 | 600 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2022 | 14652 | 0.050 |
Why?
|
Immunosorbent Techniques | 2 | 2000 | 176 | 0.050 |
Why?
|
Blood Pressure | 6 | 1998 | 8523 | 0.050 |
Why?
|
Hydrazines | 1 | 2022 | 224 | 0.050 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2002 | 327 | 0.050 |
Why?
|
Acrosome | 1 | 2000 | 10 | 0.050 |
Why?
|
Zona Pellucida | 1 | 2000 | 14 | 0.050 |
Why?
|
Sperm-Ovum Interactions | 1 | 2000 | 23 | 0.050 |
Why?
|
Antibiotics, Antitubercular | 1 | 2001 | 101 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2022 | 361 | 0.040 |
Why?
|
Flavoproteins | 1 | 2000 | 40 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 2000 | 136 | 0.040 |
Why?
|
Permeability | 1 | 2022 | 719 | 0.040 |
Why?
|
Infant | 8 | 2001 | 35941 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2007 | 5247 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 1988 | 980 | 0.040 |
Why?
|
Chalcones | 1 | 2020 | 29 | 0.040 |
Why?
|
Nephrectomy | 2 | 2004 | 1017 | 0.040 |
Why?
|
Pancreatitis | 2 | 2019 | 1100 | 0.040 |
Why?
|
Phenotype | 5 | 2020 | 16532 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2002 | 343 | 0.040 |
Why?
|
Cytokines | 2 | 2014 | 7346 | 0.040 |
Why?
|
Schistosoma mansoni | 1 | 2021 | 156 | 0.040 |
Why?
|
Cell Membrane | 3 | 2006 | 3683 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 1 | 2005 | 559 | 0.040 |
Why?
|
Radiography | 2 | 2010 | 6964 | 0.040 |
Why?
|
Iron-Sulfur Proteins | 1 | 2000 | 83 | 0.040 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2001 | 179 | 0.040 |
Why?
|
Glucose Tolerance Test | 2 | 2009 | 1174 | 0.040 |
Why?
|
Models, Statistical | 2 | 2005 | 5066 | 0.040 |
Why?
|
Vascular Surgical Procedures | 1 | 2008 | 1471 | 0.040 |
Why?
|
Parkinson Disease | 1 | 1994 | 2843 | 0.040 |
Why?
|
Lysine | 1 | 2024 | 1002 | 0.040 |
Why?
|
Forearm | 2 | 2005 | 429 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2002 | 629 | 0.040 |
Why?
|
Immunosorbents | 2 | 1998 | 21 | 0.040 |
Why?
|
Epitope Mapping | 1 | 2000 | 297 | 0.040 |
Why?
|
Propionates | 1 | 2020 | 182 | 0.040 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2000 | 140 | 0.040 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2000 | 166 | 0.040 |
Why?
|
Bacterial Infections | 2 | 1998 | 1403 | 0.040 |
Why?
|
Immune Sera | 3 | 1995 | 613 | 0.040 |
Why?
|
Isoniazid | 1 | 2001 | 283 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 985 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2000 | 145 | 0.040 |
Why?
|
Recurrence | 7 | 2012 | 8469 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2014 | 3204 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2002 | 7595 | 0.040 |
Why?
|
Actins | 1 | 2006 | 2048 | 0.040 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 3 | 2005 | 63 | 0.040 |
Why?
|
Blood Loss, Surgical | 1 | 2023 | 657 | 0.040 |
Why?
|
4-Aminobenzoic Acid | 2 | 1989 | 22 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1988 | 2198 | 0.040 |
Why?
|
Phyllodes Tumor | 1 | 1999 | 53 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 490 | 0.040 |
Why?
|
Rifampin | 1 | 2001 | 341 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2006 | 1951 | 0.040 |
Why?
|
Drug Hypersensitivity | 1 | 1988 | 909 | 0.040 |
Why?
|
Brain Death | 1 | 2002 | 356 | 0.040 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 1998 | 40 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 818 | 0.040 |
Why?
|
Gene Targeting | 1 | 2002 | 839 | 0.040 |
Why?
|
Carcinoma, Small Cell | 2 | 1998 | 416 | 0.040 |
Why?
|
Acetates | 1 | 2000 | 322 | 0.040 |
Why?
|
Merozoite Surface Protein 1 | 1 | 1998 | 37 | 0.040 |
Why?
|
Histocompatibility | 2 | 1998 | 316 | 0.040 |
Why?
|
Hepatitis C | 2 | 2021 | 1578 | 0.040 |
Why?
|
Neoplasms, Experimental | 3 | 2001 | 1229 | 0.040 |
Why?
|
Amines | 1 | 2000 | 281 | 0.040 |
Why?
|
Atrial Natriuretic Factor | 2 | 1996 | 350 | 0.040 |
Why?
|
Infusions, Intra-Arterial | 1 | 1999 | 221 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 674 | 0.040 |
Why?
|
Attitude to Health | 2 | 2004 | 2028 | 0.040 |
Why?
|
Oxidopamine | 1 | 1998 | 172 | 0.040 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2019 | 129 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2001 | 548 | 0.040 |
Why?
|
Mannose | 2 | 1989 | 121 | 0.040 |
Why?
|
Asthma | 3 | 1993 | 6161 | 0.040 |
Why?
|
Tea | 1 | 2020 | 284 | 0.040 |
Why?
|
Electrodes | 1 | 2001 | 613 | 0.040 |
Why?
|
Precancerous Conditions | 2 | 2020 | 979 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2010 | 3556 | 0.040 |
Why?
|
Porphyrins | 1 | 2000 | 352 | 0.040 |
Why?
|
Cell Line | 7 | 2019 | 15636 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2002 | 859 | 0.040 |
Why?
|
Videoconferencing | 1 | 2020 | 199 | 0.040 |
Why?
|
Lymphokines | 1 | 2001 | 929 | 0.040 |
Why?
|
Autoantibodies | 1 | 2007 | 2116 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 551 | 0.040 |
Why?
|
Genome, Viral | 1 | 2002 | 657 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2006 | 2201 | 0.040 |
Why?
|
Radioimmunoassay | 2 | 1997 | 866 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 1056 | 0.040 |
Why?
|
Anti-Anxiety Agents | 1 | 2000 | 397 | 0.040 |
Why?
|
Leukocyte Count | 2 | 2020 | 1599 | 0.040 |
Why?
|
Proteinuria | 2 | 2001 | 594 | 0.040 |
Why?
|
Acrylates | 2 | 1987 | 79 | 0.040 |
Why?
|
Carcinoid Tumor | 1 | 1999 | 228 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2018 | 390 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 776 | 0.040 |
Why?
|
Radio Waves | 1 | 1999 | 250 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2021 | 1456 | 0.040 |
Why?
|
Schistosoma japonicum | 1 | 1997 | 5 | 0.040 |
Why?
|
Laminin | 1 | 1999 | 405 | 0.040 |
Why?
|
Monocytes | 1 | 2006 | 2575 | 0.040 |
Why?
|
Methacrylates | 2 | 1987 | 108 | 0.040 |
Why?
|
Blotting, Southern | 2 | 2000 | 779 | 0.040 |
Why?
|
Norepinephrine | 2 | 1998 | 899 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 674 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2021 | 14381 | 0.040 |
Why?
|
Gene Transfer Techniques | 1 | 2002 | 1204 | 0.040 |
Why?
|
Iliac Artery | 1 | 1998 | 345 | 0.040 |
Why?
|
Laser Therapy | 1 | 2024 | 1093 | 0.040 |
Why?
|
Graft vs Host Reaction | 1 | 1997 | 103 | 0.040 |
Why?
|
Osteoclasts | 1 | 2001 | 712 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2002 | 1345 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1183 | 0.030 |
Why?
|
Thiazoles | 2 | 2001 | 1501 | 0.030 |
Why?
|
Insulin | 3 | 2009 | 6591 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2008 | 3664 | 0.030 |
Why?
|
Head and Neck Neoplasms | 3 | 2007 | 2876 | 0.030 |
Why?
|
Skin | 1 | 2010 | 4467 | 0.030 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 1999 | 462 | 0.030 |
Why?
|
Tropomyosin | 1 | 1997 | 104 | 0.030 |
Why?
|
Renal Artery | 1 | 1998 | 368 | 0.030 |
Why?
|
Choline | 1 | 2018 | 513 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2007 | 2750 | 0.030 |
Why?
|
Cohort Studies | 5 | 2021 | 41247 | 0.030 |
Why?
|
Photosynthesis | 1 | 2016 | 70 | 0.030 |
Why?
|
Antimanic Agents | 1 | 2000 | 520 | 0.030 |
Why?
|
False Negative Reactions | 2 | 2012 | 574 | 0.030 |
Why?
|
Anilides | 1 | 2019 | 409 | 0.030 |
Why?
|
Elbow | 1 | 1997 | 130 | 0.030 |
Why?
|
Herpes Simplex | 1 | 2000 | 477 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3570 | 0.030 |
Why?
|
Plant Leaves | 1 | 2016 | 150 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2007 | 4025 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2000 | 701 | 0.030 |
Why?
|
Peritoneal Lavage | 1 | 1996 | 31 | 0.030 |
Why?
|
Vaccination | 2 | 2000 | 3354 | 0.030 |
Why?
|
Exercise Therapy | 3 | 1995 | 917 | 0.030 |
Why?
|
Rats, Inbred BN | 1 | 1996 | 231 | 0.030 |
Why?
|
Medical Illustration | 1 | 1997 | 135 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2001 | 1021 | 0.030 |
Why?
|
Cyclin D1 | 1 | 1998 | 453 | 0.030 |
Why?
|
Glycosylation | 2 | 1996 | 1092 | 0.030 |
Why?
|
Cytoskeletal Proteins | 2 | 1995 | 1344 | 0.030 |
Why?
|
Hypertension, Renovascular | 1 | 1996 | 117 | 0.030 |
Why?
|
Spermatozoa | 1 | 2000 | 633 | 0.030 |
Why?
|
Plant Lectins | 1 | 1996 | 103 | 0.030 |
Why?
|
Proteomics | 2 | 2023 | 3804 | 0.030 |
Why?
|
Radiation Chimera | 1 | 1995 | 216 | 0.030 |
Why?
|
Intraoperative Period | 1 | 1997 | 516 | 0.030 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1996 | 322 | 0.030 |
Why?
|
alpha Catenin | 1 | 1995 | 37 | 0.030 |
Why?
|
Serologic Tests | 1 | 1997 | 383 | 0.030 |
Why?
|
Pancreatectomy | 1 | 2020 | 809 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1997 | 301 | 0.030 |
Why?
|
Transplants | 1 | 1998 | 206 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2000 | 782 | 0.030 |
Why?
|
Heat-Shock Proteins | 2 | 1992 | 796 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2023 | 1914 | 0.030 |
Why?
|
Hexosamines | 2 | 1992 | 40 | 0.030 |
Why?
|
Immunoglobulin M | 2 | 2000 | 1529 | 0.030 |
Why?
|
Myofibroblasts | 1 | 2017 | 207 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2017 | 231 | 0.030 |
Why?
|
Weight Lifting | 1 | 1995 | 126 | 0.030 |
Why?
|
Ligands | 2 | 2019 | 3275 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2014 | 3205 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1998 | 982 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2018 | 600 | 0.030 |
Why?
|
Heart Arrest | 2 | 2002 | 1503 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 1996 | 243 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1996 | 575 | 0.030 |
Why?
|
Pregnancy | 1 | 1997 | 29658 | 0.030 |
Why?
|
Copper | 1 | 2017 | 367 | 0.030 |
Why?
|
Carcinoma, Merkel Cell | 1 | 1999 | 321 | 0.030 |
Why?
|
Precipitin Tests | 1 | 1995 | 815 | 0.030 |
Why?
|
Phytohemagglutinins | 1 | 1994 | 168 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2017 | 5194 | 0.030 |
Why?
|
Lung | 2 | 2023 | 9982 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 1998 | 924 | 0.030 |
Why?
|
Likelihood Functions | 1 | 1998 | 988 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2010 | 11476 | 0.030 |
Why?
|
Genetic Variation | 3 | 2009 | 6531 | 0.030 |
Why?
|
Antigens | 1 | 2000 | 1446 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1438 | 0.030 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2001 | 832 | 0.030 |
Why?
|
Postoperative Care | 1 | 2001 | 1478 | 0.030 |
Why?
|
Rh-Hr Blood-Group System | 1 | 1994 | 65 | 0.030 |
Why?
|
beta Catenin | 1 | 2019 | 1043 | 0.030 |
Why?
|
Adipocytes | 1 | 2001 | 1179 | 0.030 |
Why?
|
Photochemotherapy | 1 | 2000 | 808 | 0.030 |
Why?
|
Quinolines | 1 | 2019 | 758 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 800 | 0.030 |
Why?
|
Multidrug Resistance-Associated Proteins | 2 | 2007 | 104 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2000 | 1132 | 0.030 |
Why?
|
Cloning, Molecular | 3 | 2000 | 4171 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 1997 | 300 | 0.030 |
Why?
|
Taxoids | 1 | 2017 | 668 | 0.030 |
Why?
|
Cell Survival | 3 | 2015 | 5796 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 3 | 2020 | 3152 | 0.030 |
Why?
|
Cryosurgery | 1 | 1999 | 471 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2018 | 1247 | 0.030 |
Why?
|
Mycoses | 1 | 1997 | 387 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 2014 | 221 | 0.030 |
Why?
|
Thymus Gland | 3 | 1985 | 1246 | 0.030 |
Why?
|
Nerve Tissue Proteins | 2 | 1997 | 4409 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 1085 | 0.030 |
Why?
|
Rats, Inbred Strains | 3 | 1990 | 2094 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 1996 | 480 | 0.030 |
Why?
|
Injections | 1 | 1996 | 832 | 0.030 |
Why?
|
Cytoplasm | 2 | 1995 | 1521 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 1998 | 640 | 0.030 |
Why?
|
Lymphedema | 1 | 2000 | 525 | 0.030 |
Why?
|
Triage | 1 | 2020 | 982 | 0.030 |
Why?
|
Bicuspid | 1 | 2013 | 69 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 1996 | 606 | 0.030 |
Why?
|
Oligopeptides | 1 | 1998 | 1187 | 0.030 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1993 | 117 | 0.030 |
Why?
|
Odontogenesis | 1 | 2013 | 65 | 0.030 |
Why?
|
Forecasting | 1 | 2002 | 2931 | 0.030 |
Why?
|
Foot | 1 | 1997 | 573 | 0.030 |
Why?
|
Levodopa | 1 | 1994 | 217 | 0.030 |
Why?
|
Collagenases | 1 | 1993 | 220 | 0.030 |
Why?
|
Acetylglucosamine | 1 | 1994 | 189 | 0.030 |
Why?
|
Pulse | 1 | 1993 | 218 | 0.030 |
Why?
|
RNA, Catalytic | 1 | 1993 | 53 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2024 | 8157 | 0.030 |
Why?
|
Periodontal Attachment Loss | 1 | 2013 | 144 | 0.030 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5500 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2225 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2003 | 1999 | 0.030 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2001 | 931 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2000 | 947 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1836 | 0.030 |
Why?
|
Adiponectin | 1 | 2018 | 1116 | 0.030 |
Why?
|
Water | 1 | 2019 | 1401 | 0.030 |
Why?
|
Equipment Design | 1 | 2001 | 3529 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2007 | 4435 | 0.030 |
Why?
|
Naphthalenes | 1 | 1993 | 198 | 0.030 |
Why?
|
Eosinophils | 2 | 1998 | 946 | 0.030 |
Why?
|
Hydroxyproline | 1 | 2012 | 110 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2001 | 1374 | 0.030 |
Why?
|
Cattle | 6 | 1998 | 3844 | 0.030 |
Why?
|
Clone Cells | 1 | 1996 | 1663 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 1998 | 758 | 0.030 |
Why?
|
Staining and Labeling | 2 | 1995 | 1090 | 0.030 |
Why?
|
Cardiac Output, Low | 1 | 1993 | 192 | 0.030 |
Why?
|
Molar | 1 | 2013 | 156 | 0.030 |
Why?
|
Cholecystolithiasis | 1 | 2011 | 7 | 0.030 |
Why?
|
Radiation Injuries | 1 | 2019 | 1183 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 2 | 2007 | 613 | 0.030 |
Why?
|
rho-Associated Kinases | 3 | 1998 | 280 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2013 | 124 | 0.030 |
Why?
|
Angioplasty, Balloon | 1 | 1996 | 600 | 0.030 |
Why?
|
Therapies, Investigational | 1 | 2013 | 111 | 0.030 |
Why?
|
Histocytochemistry | 1 | 1993 | 693 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4262 | 0.030 |
Why?
|
Crystallization | 1 | 1993 | 534 | 0.020 |
Why?
|
Angina Pectoris | 1 | 1996 | 970 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 1996 | 739 | 0.020 |
Why?
|
Substantia Nigra | 1 | 1994 | 350 | 0.020 |
Why?
|
Bone Marrow Transplantation | 2 | 1997 | 2696 | 0.020 |
Why?
|
Mice, SCID | 1 | 2017 | 2628 | 0.020 |
Why?
|
Interphase | 2 | 1998 | 229 | 0.020 |
Why?
|
Razoxane | 1 | 1991 | 43 | 0.020 |
Why?
|
Aldosterone | 1 | 1996 | 868 | 0.020 |
Why?
|
Calcium | 2 | 1998 | 5721 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 801 | 0.020 |
Why?
|
Hand | 1 | 1997 | 903 | 0.020 |
Why?
|
Endothelial Cells | 3 | 2012 | 3537 | 0.020 |
Why?
|
Drug Synergism | 1 | 1996 | 1755 | 0.020 |
Why?
|
Reoperation | 2 | 2018 | 4287 | 0.020 |
Why?
|
Microcomputers | 1 | 1992 | 141 | 0.020 |
Why?
|
Dental Clinics | 1 | 2011 | 30 | 0.020 |
Why?
|
Brain Chemistry | 1 | 1995 | 959 | 0.020 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1135 | 0.020 |
Why?
|
Mitochondria | 2 | 2006 | 3600 | 0.020 |
Why?
|
Topoisomerase II Inhibitors | 1 | 1991 | 96 | 0.020 |
Why?
|
Hepatitis B | 1 | 1997 | 696 | 0.020 |
Why?
|
Tooth Loss | 1 | 2013 | 198 | 0.020 |
Why?
|
DNA Probes | 1 | 1992 | 551 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1588 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1619 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 777 | 0.020 |
Why?
|
Lauric Acids | 1 | 1990 | 9 | 0.020 |
Why?
|
Fatigue | 1 | 1998 | 1543 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2016 | 15815 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 1631 | 0.020 |
Why?
|
Thymoma | 2 | 1983 | 187 | 0.020 |
Why?
|
Administration, Rectal | 1 | 1990 | 70 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 1997 | 1493 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2191 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2001 | 2704 | 0.020 |
Why?
|
Malaria, Falciparum | 1 | 1998 | 1076 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7790 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 2 | 2003 | 490 | 0.020 |
Why?
|
Length of Stay | 1 | 2004 | 6452 | 0.020 |
Why?
|
Linear Models | 1 | 2000 | 5876 | 0.020 |
Why?
|
Amino Acids | 1 | 1996 | 1715 | 0.020 |
Why?
|
Flow Cytometry | 3 | 2013 | 5870 | 0.020 |
Why?
|
Protein Kinases | 1 | 1997 | 1612 | 0.020 |
Why?
|
Survivors | 1 | 2000 | 2356 | 0.020 |
Why?
|
Glucuronosyltransferase | 1 | 1990 | 130 | 0.020 |
Why?
|
Caprylates | 1 | 1990 | 108 | 0.020 |
Why?
|
Microglia | 1 | 1998 | 1347 | 0.020 |
Why?
|
DNA | 2 | 1996 | 7237 | 0.020 |
Why?
|
Hemolysis | 1 | 1991 | 423 | 0.020 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2010 | 70 | 0.020 |
Why?
|
Clostridium | 1 | 1989 | 100 | 0.020 |
Why?
|
Biological Availability | 1 | 1990 | 395 | 0.020 |
Why?
|
Cholecystectomy | 1 | 2011 | 406 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2979 | 0.020 |
Why?
|
Osteopontin | 2 | 2003 | 303 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3762 | 0.020 |
Why?
|
Cell Nucleus | 3 | 2006 | 2911 | 0.020 |
Why?
|
Serum Albumin | 1 | 1992 | 675 | 0.020 |
Why?
|
Biological Assay | 1 | 1992 | 630 | 0.020 |
Why?
|
Gallstones | 1 | 2011 | 285 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 1989 | 248 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2017 | 1955 | 0.020 |
Why?
|
Myocardium | 4 | 1998 | 4680 | 0.020 |
Why?
|
Indoles | 1 | 2017 | 1828 | 0.020 |
Why?
|
Dexamethasone | 1 | 1996 | 1927 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1483 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2896 | 0.020 |
Why?
|
Renal Circulation | 1 | 1989 | 292 | 0.020 |
Why?
|
3T3 Cells | 2 | 2001 | 1085 | 0.020 |
Why?
|
Mathematics | 1 | 2009 | 708 | 0.020 |
Why?
|
Aerosols | 1 | 1991 | 633 | 0.020 |
Why?
|
Biological Factors | 1 | 1989 | 158 | 0.020 |
Why?
|
Mouth Neoplasms | 1 | 1993 | 593 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6242 | 0.020 |
Why?
|
Leukocytes | 1 | 1996 | 2030 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 1996 | 1972 | 0.020 |
Why?
|
General Surgery | 2 | 1997 | 1681 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1738 | 0.020 |
Why?
|
Anti-Bacterial Agents | 3 | 1998 | 7380 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 1989 | 825 | 0.020 |
Why?
|
Genes, ras | 1 | 2010 | 654 | 0.020 |
Why?
|
Salmonella | 1 | 1988 | 128 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 1997 | 2274 | 0.020 |
Why?
|
Arterioles | 1 | 2008 | 250 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 1997 | 4546 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 829 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2012 | 509 | 0.020 |
Why?
|
HLA-D Antigens | 1 | 1987 | 134 | 0.020 |
Why?
|
Caveolae | 1 | 2007 | 55 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1998 | 3724 | 0.020 |
Why?
|
Research | 1 | 1996 | 1972 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3449 | 0.020 |
Why?
|
Benzamidines | 1 | 1987 | 23 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1972 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1434 | 0.020 |
Why?
|
Mast-Cell Sarcoma | 1 | 1986 | 46 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 2 | 2000 | 3217 | 0.020 |
Why?
|
Cyclodextrins | 1 | 1987 | 65 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1158 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1996 | 2142 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1989 | 592 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2016 | 17750 | 0.020 |
Why?
|
Fibroblasts | 3 | 2002 | 4084 | 0.020 |
Why?
|
Esters | 1 | 1987 | 211 | 0.020 |
Why?
|
Aromatase | 1 | 2006 | 147 | 0.020 |
Why?
|
Glutathione Transferase | 2 | 1998 | 565 | 0.020 |
Why?
|
Wood | 1 | 1986 | 91 | 0.020 |
Why?
|
Mast Cells | 1 | 1993 | 1428 | 0.020 |
Why?
|
Cyclohexanes | 1 | 2006 | 152 | 0.020 |
Why?
|
Heart | 1 | 1998 | 4390 | 0.020 |
Why?
|
Ethanol | 1 | 1992 | 1314 | 0.020 |
Why?
|
Kidney Neoplasms | 2 | 2000 | 4312 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1990 | 2235 | 0.020 |
Why?
|
Antimalarials | 1 | 1992 | 907 | 0.020 |
Why?
|
Bronchi | 1 | 1989 | 846 | 0.020 |
Why?
|
Catalysis | 2 | 2000 | 775 | 0.020 |
Why?
|
Biological Transport | 2 | 2002 | 2086 | 0.020 |
Why?
|
Ticlopidine | 2 | 1987 | 895 | 0.020 |
Why?
|
Sesquiterpenes | 1 | 2006 | 176 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2006 | 389 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 1997 | 3438 | 0.020 |
Why?
|
Catheterization | 2 | 2002 | 1433 | 0.020 |
Why?
|
Pyuria | 2 | 1997 | 30 | 0.010 |
Why?
|
S100 Proteins | 1 | 2005 | 218 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1995 | 3021 | 0.010 |
Why?
|
Hemophilia A | 1 | 1988 | 360 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2415 | 0.010 |
Why?
|
Electrocardiography | 2 | 1996 | 6400 | 0.010 |
Why?
|
Barrett Esophagus | 1 | 2008 | 490 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 1993 | 1152 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 1997 | 3854 | 0.010 |
Why?
|
Muscle, Skeletal | 2 | 1997 | 4922 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 1135 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2006 | 575 | 0.010 |
Why?
|
Private Sector | 1 | 2007 | 398 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 1007 | 0.010 |
Why?
|
Gene Frequency | 1 | 2011 | 3603 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2007 | 2558 | 0.010 |
Why?
|
Zinc Oxide-Eugenol Cement | 1 | 2003 | 9 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2006 | 956 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1997 | 3193 | 0.010 |
Why?
|
Bacteriuria | 2 | 1997 | 104 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 1998 | 2867 | 0.010 |
Why?
|
Arteries | 1 | 2008 | 1115 | 0.010 |
Why?
|
Protein Binding | 1 | 1995 | 9334 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8000 | 0.010 |
Why?
|
Amino Acid Transport System ASC | 1 | 2002 | 15 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2000 | 5076 | 0.010 |
Why?
|
Plasmids | 1 | 1988 | 2277 | 0.010 |
Why?
|
Cultural Characteristics | 1 | 2004 | 254 | 0.010 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2002 | 72 | 0.010 |
Why?
|
Diathermy | 1 | 2002 | 17 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1024 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2006 | 1095 | 0.010 |
Why?
|
Growth Substances | 1 | 1985 | 768 | 0.010 |
Why?
|
Fructosamine | 2 | 1992 | 14 | 0.010 |
Why?
|
Rest | 1 | 2007 | 914 | 0.010 |
Why?
|
Body Weight | 2 | 2009 | 4608 | 0.010 |
Why?
|
Postmortem Changes | 2 | 1992 | 119 | 0.010 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1982 | 66 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 1996 | 3863 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1996 | 3072 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8002 | 0.010 |
Why?
|
Microscopy | 1 | 2007 | 880 | 0.010 |
Why?
|
Floxuridine | 1 | 2001 | 43 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2002 | 293 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 2001 | 92 | 0.010 |
Why?
|
Astrocytoma | 2 | 1997 | 775 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 2001 | 122 | 0.010 |
Why?
|
Oxygen | 1 | 1993 | 4188 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 1990 | 2413 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1993 | 4560 | 0.010 |
Why?
|
Membrane Transport Proteins | 1 | 2007 | 1035 | 0.010 |
Why?
|
Chromatography, Affinity | 3 | 1992 | 535 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 1544 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3890 | 0.010 |
Why?
|
Chlorophyllides | 1 | 2000 | 53 | 0.010 |
Why?
|
Technetium | 1 | 2001 | 321 | 0.010 |
Why?
|
Acrosome Reaction | 1 | 2000 | 7 | 0.010 |
Why?
|
Ubiquitin | 1 | 2006 | 838 | 0.010 |
Why?
|
Models, Animal | 1 | 2007 | 2118 | 0.010 |
Why?
|
Waiting Lists | 1 | 2005 | 750 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2006 | 1788 | 0.010 |
Why?
|
Cytoskeleton | 1 | 1985 | 1167 | 0.010 |
Why?
|
Carcinoma, Embryonal | 1 | 2000 | 37 | 0.010 |
Why?
|
DNA Damage | 2 | 2006 | 2442 | 0.010 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2001 | 156 | 0.010 |
Why?
|
Mitomycin | 1 | 2001 | 262 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2000 | 144 | 0.010 |
Why?
|
Osteoprotegerin | 1 | 2001 | 177 | 0.010 |
Why?
|
DNA Replication | 2 | 1988 | 1413 | 0.010 |
Why?
|
Angiography | 2 | 2002 | 1608 | 0.010 |
Why?
|
Stroke Volume | 1 | 1994 | 5497 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9274 | 0.010 |
Why?
|
Materials Testing | 1 | 2003 | 857 | 0.010 |
Why?
|
Etoposide | 1 | 2001 | 628 | 0.010 |
Why?
|
Gamma Rays | 1 | 2001 | 316 | 0.010 |
Why?
|
Malignant Carcinoid Syndrome | 1 | 1999 | 30 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2003 | 1351 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 749 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 522 | 0.010 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 1983 | 491 | 0.010 |
Why?
|
Algorithms | 2 | 2013 | 13946 | 0.010 |
Why?
|
Sulfonylurea Compounds | 1 | 2001 | 221 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2006 | 1314 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5793 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 2 | 1998 | 3732 | 0.010 |
Why?
|
Thymus Neoplasms | 1 | 1982 | 274 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1992 | 1055 | 0.010 |
Why?
|
Antilymphocyte Serum | 1 | 2000 | 482 | 0.010 |
Why?
|
Marine Toxins | 1 | 1998 | 24 | 0.010 |
Why?
|
Okadaic Acid | 1 | 1998 | 67 | 0.010 |
Why?
|
Cross Reactions | 2 | 1994 | 818 | 0.010 |
Why?
|
Genes, bcl-2 | 1 | 1998 | 119 | 0.010 |
Why?
|
PC12 Cells | 1 | 1998 | 317 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 584 | 0.010 |
Why?
|
Anaphase | 1 | 1998 | 116 | 0.010 |
Why?
|
Antibodies, Neoplasm | 1 | 1999 | 280 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1998 | 213 | 0.010 |
Why?
|
Phosphoserine | 1 | 1998 | 203 | 0.010 |
Why?
|
Drug Eruptions | 1 | 2001 | 335 | 0.010 |
Why?
|
Protein Phosphatase 1 | 1 | 1998 | 135 | 0.010 |
Why?
|
Physicians | 1 | 1996 | 4586 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 2 | 1997 | 1705 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2001 | 563 | 0.010 |
Why?
|
Occupational Diseases | 1 | 1986 | 1484 | 0.010 |
Why?
|
Software | 1 | 1992 | 4421 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1998 | 238 | 0.010 |
Why?
|
Kidney Papillary Necrosis | 1 | 1997 | 3 | 0.010 |
Why?
|
Intermediate Filaments | 1 | 1998 | 173 | 0.010 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2000 | 330 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 426 | 0.010 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1997 | 87 | 0.010 |
Why?
|
Guanosine Diphosphate | 1 | 1997 | 80 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 1998 | 316 | 0.010 |
Why?
|
Gamma Cameras | 1 | 1997 | 34 | 0.010 |
Why?
|
Decision Trees | 1 | 1999 | 506 | 0.010 |
Why?
|
Kidney Diseases, Cystic | 1 | 1998 | 183 | 0.010 |
Why?
|
Hypertriglyceridemia | 1 | 2000 | 316 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 1997 | 186 | 0.010 |
Why?
|
Oxazoles | 1 | 1998 | 198 | 0.010 |
Why?
|
Furans | 1 | 1998 | 198 | 0.010 |
Why?
|
Educational Status | 1 | 2004 | 2511 | 0.010 |
Why?
|
Cystitis | 1 | 1997 | 96 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1998 | 231 | 0.010 |
Why?
|
Punctures | 1 | 1998 | 368 | 0.010 |
Why?
|
rho GTP-Binding Proteins | 1 | 1998 | 277 | 0.010 |
Why?
|
Vasculitis | 1 | 2001 | 524 | 0.010 |
Why?
|
Protein Subunits | 1 | 2000 | 943 | 0.010 |
Why?
|
Antigens, Protozoan | 1 | 1998 | 315 | 0.010 |
Why?
|
Leukemia | 1 | 1985 | 1511 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 1997 | 328 | 0.010 |
Why?
|
Cricetinae | 1 | 2000 | 2427 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1996 | 361 | 0.010 |
Why?
|
Thymidine | 1 | 1996 | 300 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1996 | 306 | 0.010 |
Why?
|
Vasopressins | 1 | 1998 | 355 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1996 | 330 | 0.010 |
Why?
|
Hepatitis B Antibodies | 1 | 1997 | 157 | 0.010 |
Why?
|
Protein Phosphatase 2 | 1 | 1998 | 236 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 1129 | 0.010 |
Why?
|
Chromatography | 1 | 1996 | 189 | 0.010 |
Why?
|
Culture Media | 1 | 1998 | 899 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1997 | 433 | 0.010 |
Why?
|
Blood Platelets | 1 | 1987 | 2522 | 0.010 |
Why?
|
Neoplasms, Unknown Primary | 1 | 1997 | 102 | 0.010 |
Why?
|
Phosphopeptides | 1 | 1997 | 241 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2177 | 0.010 |
Why?
|
Internship and Residency | 1 | 1996 | 5861 | 0.010 |
Why?
|
Caspase 3 | 1 | 1998 | 730 | 0.010 |
Why?
|
Heart Failure | 2 | 1997 | 11833 | 0.010 |
Why?
|
Aneurysm | 1 | 1998 | 337 | 0.010 |
Why?
|
Detergents | 1 | 1996 | 235 | 0.010 |
Why?
|
Chimera | 1 | 1996 | 453 | 0.010 |
Why?
|
Oocytes | 1 | 2000 | 1169 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1998 | 755 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 2000 | 784 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1997 | 899 | 0.010 |
Why?
|
Receptors, Interleukin-6 | 1 | 1996 | 226 | 0.010 |
Why?
|
Cardiac Output | 1 | 1997 | 837 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1996 | 630 | 0.010 |
Why?
|
Rabbits | 1 | 2001 | 4772 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2001 | 1265 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1998 | 1616 | 0.010 |
Why?
|
Brachytherapy | 1 | 2002 | 1239 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1062 | 0.010 |
Why?
|
Risk | 1 | 2006 | 9623 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 1998 | 651 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1998 | 1101 | 0.010 |
Why?
|
Tanzania | 1 | 1998 | 1374 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12106 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2000 | 1816 | 0.010 |
Why?
|
Chloromercuribenzoates | 1 | 1973 | 5 | 0.010 |
Why?
|
Candida albicans | 1 | 1997 | 377 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2000 | 935 | 0.010 |
Why?
|
Polycyclic Compounds | 1 | 1993 | 29 | 0.010 |
Why?
|
Pathology | 1 | 1997 | 270 | 0.010 |
Why?
|
Lectins | 1 | 1996 | 485 | 0.010 |
Why?
|
Mercaptoethanol | 1 | 1973 | 63 | 0.010 |
Why?
|
Ethylmaleimide | 1 | 1973 | 70 | 0.010 |
Why?
|
Nuclear Medicine | 1 | 1997 | 236 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1995 | 8953 | 0.010 |
Why?
|
Dithiothreitol | 1 | 1973 | 95 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 951 | 0.010 |
Why?
|
Blood Preservation | 1 | 1994 | 168 | 0.010 |
Why?
|
Mood Disorders | 1 | 2000 | 1123 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2000 | 1155 | 0.010 |
Why?
|
Brain | 3 | 1998 | 26863 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 1993 | 72 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1973 | 299 | 0.010 |
Why?
|
Tetrahymena | 1 | 1993 | 10 | 0.010 |
Why?
|
Templates, Genetic | 1 | 1973 | 190 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 1973 | 189 | 0.010 |
Why?
|
Perfusion | 1 | 1998 | 1376 | 0.010 |
Why?
|
Tritium | 1 | 1973 | 707 | 0.010 |
Why?
|
Rats, Inbred BUF | 2 | 1983 | 19 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1997 | 1792 | 0.010 |
Why?
|
Mathematical Computing | 1 | 1993 | 143 | 0.010 |
Why?
|
Hot Temperature | 2 | 1992 | 1434 | 0.010 |
Why?
|
Electrochemistry | 1 | 1993 | 143 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1973 | 644 | 0.010 |
Why?
|
Triglycerides | 1 | 2000 | 2475 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1994 | 513 | 0.010 |
Why?
|
Solubility | 1 | 1994 | 1087 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 819 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2002 | 1412 | 0.010 |
Why?
|
Fertilization in Vitro | 1 | 2000 | 1296 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 1998 | 1973 | 0.010 |
Why?
|
Diketopiperazines | 1 | 1991 | 23 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1996 | 12268 | 0.010 |
Why?
|
Stereoisomerism | 1 | 1993 | 618 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1993 | 548 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2000 | 1442 | 0.010 |
Why?
|
Drug Interactions | 1 | 1996 | 1424 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20031 | 0.010 |
Why?
|
Cholesterol | 1 | 2000 | 2923 | 0.010 |
Why?
|
Colorimetry | 1 | 1991 | 153 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 1992 | 238 | 0.010 |
Why?
|
Sodium | 1 | 1996 | 1601 | 0.010 |
Why?
|
Mitral Valve Stenosis | 1 | 1993 | 347 | 0.010 |
Why?
|
Cerebral Arteries | 1 | 1973 | 490 | 0.010 |
Why?
|
Models, Chemical | 1 | 1993 | 615 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2001 | 2627 | 0.010 |
Why?
|
Secondary Prevention | 1 | 1997 | 1550 | 0.010 |
Why?
|
Cell Separation | 1 | 1996 | 1724 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1997 | 2364 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 1993 | 633 | 0.010 |
Why?
|
Geriatrics | 2 | 1965 | 385 | 0.010 |
Why?
|
Aging | 1 | 2009 | 8634 | 0.010 |
Why?
|
Rats, Inbred WKY | 1 | 1989 | 151 | 0.010 |
Why?
|
Family | 1 | 2000 | 3189 | 0.010 |
Why?
|
Autopsy | 1 | 1973 | 1006 | 0.010 |
Why?
|
Tissue Extracts | 1 | 1989 | 140 | 0.010 |
Why?
|
Isoproterenol | 1 | 1989 | 394 | 0.010 |
Why?
|
Cell Aggregation | 1 | 1989 | 239 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 4716 | 0.010 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1988 | 31 | 0.000 |
Why?
|
Protein Kinase C | 1 | 1993 | 1201 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1988 | 169 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1973 | 2509 | 0.000 |
Why?
|
Lung Diseases, Obstructive | 1 | 1989 | 308 | 0.000 |
Why?
|
Bilirubin | 1 | 1990 | 438 | 0.000 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1988 | 217 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1988 | 553 | 0.000 |
Why?
|
Atrophy | 1 | 1973 | 1625 | 0.000 |
Why?
|
Registries | 1 | 2004 | 8434 | 0.000 |
Why?
|
Organ Size | 1 | 1993 | 2248 | 0.000 |
Why?
|
RNA, Viral | 1 | 1996 | 2837 | 0.000 |
Why?
|
Swine | 1 | 1998 | 5903 | 0.000 |
Why?
|
Lung Diseases | 1 | 1998 | 1915 | 0.000 |
Why?
|
Respiratory Hypersensitivity | 1 | 1989 | 272 | 0.000 |
Why?
|
Alleles | 1 | 1998 | 6897 | 0.000 |
Why?
|
Astrocytes | 1 | 1995 | 1333 | 0.000 |
Why?
|
Regression Analysis | 1 | 1996 | 6359 | 0.000 |
Why?
|
Myocardial Ischemia | 1 | 1997 | 2161 | 0.000 |
Why?
|
Angiotensin II | 1 | 1989 | 850 | 0.000 |
Why?
|
Mitosis | 1 | 1991 | 1195 | 0.000 |
Why?
|
Deer | 1 | 1985 | 14 | 0.000 |
Why?
|
Bacteria | 1 | 1997 | 2188 | 0.000 |
Why?
|
Cerebellum | 1 | 1973 | 1495 | 0.000 |
Why?
|
RNA Splicing | 1 | 1990 | 915 | 0.000 |
Why?
|
Dinoprostone | 1 | 1988 | 599 | 0.000 |
Why?
|
Mice, Inbred AKR | 1 | 1985 | 104 | 0.000 |
Why?
|
Transforming Growth Factors | 1 | 1985 | 75 | 0.000 |
Why?
|
Sulfobromophthalein | 1 | 1964 | 9 | 0.000 |
Why?
|
Septum Pellucidum | 1 | 1965 | 54 | 0.000 |
Why?
|
Hypoproteinemia | 1 | 1964 | 12 | 0.000 |
Why?
|
Chemistry | 1 | 1985 | 348 | 0.000 |
Why?
|
Endothelium | 1 | 1987 | 764 | 0.000 |
Why?
|
Ventricular Dysfunction, Left | 1 | 1996 | 2128 | 0.000 |
Why?
|
Chemical Phenomena | 1 | 1985 | 508 | 0.000 |
Why?
|
Virulence | 1 | 1988 | 1294 | 0.000 |
Why?
|
Binding Sites | 1 | 1993 | 6053 | 0.000 |
Why?
|
Walking | 1 | 1990 | 1187 | 0.000 |
Why?
|
DNA, Bacterial | 1 | 1988 | 1454 | 0.000 |
Why?
|
Angiocardiography | 1 | 1962 | 153 | 0.000 |
Why?
|
Models, Molecular | 1 | 1993 | 5427 | 0.000 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1991 | 1524 | 0.000 |
Why?
|
Cerebral Ventricles | 1 | 1965 | 543 | 0.000 |
Why?
|
Wounds, Stab | 1 | 1962 | 72 | 0.000 |
Why?
|
Laparotomy | 1 | 1964 | 468 | 0.000 |
Why?
|
Islets of Langerhans | 1 | 1988 | 1340 | 0.000 |
Why?
|
Chymotrypsin | 1 | 1981 | 138 | 0.000 |
Why?
|
Smoking | 1 | 1998 | 9066 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2001 | 26109 | 0.000 |
Why?
|
Trypsin | 1 | 1981 | 496 | 0.000 |
Why?
|
Depression | 1 | 2000 | 8026 | 0.000 |
Why?
|
Microtubule-Associated Proteins | 1 | 1985 | 1078 | 0.000 |
Why?
|
Heart Injuries | 1 | 1962 | 208 | 0.000 |
Why?
|
Gastrectomy | 1 | 1965 | 668 | 0.000 |
Why?
|
Glioblastoma | 1 | 1995 | 3482 | 0.000 |
Why?
|
Microtubules | 1 | 1985 | 1072 | 0.000 |
Why?
|
Cysts | 1 | 1965 | 684 | 0.000 |
Why?
|
Energy Metabolism | 1 | 1990 | 2869 | 0.000 |
Why?
|
Computer Simulation | 1 | 1993 | 6195 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1981 | 1432 | 0.000 |
Why?
|
Fibroblast Growth Factors | 1 | 1985 | 867 | 0.000 |
Why?
|
Species Specificity | 1 | 1981 | 2412 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1973 | 5754 | 0.000 |
Why?
|
Hypertension | 1 | 1996 | 8594 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1964 | 1190 | 0.000 |
Why?
|
Anemia | 1 | 1964 | 1509 | 0.000 |
Why?
|
Sepsis | 1 | 1989 | 2594 | 0.000 |
Why?
|
Surgical Procedures, Operative | 1 | 1964 | 1914 | 0.000 |
Why?
|